Pharmacogenomics Education Program
Pharmacogenomics Education Program 
Manager: gmkuo |
send a message
Description: Program Description: The field of genomics and its scientific discoveries are developing at a dazzling pace. Pharmacogenomics has a promising potential to increase the response rate of drug therapy and decrease the events of adverse drug reactions. It may help us focus on safe and effective drug management to provide personalized medicine by delivering therapy with the right drug at the right dose to the right patient. Currently, however, pharmacogenomics education materials are not readily available to healthcare professionals. Furthermore, there appears to be a gap between healthcare providers’ knowledge and the expectations of patients regarding pharmacogenomics testing. The “Pharmacogenomics Education Program: Bridging the Gap between Science and Practice” (PharmGenEd) is an evidence-based pharmacogenomics education program designed for pharmacists, students, and other healthcare professionals. The program team at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences is collaborating with the American Association of Colleges of Pharmacy, the American Society of Health-System Pharmacists, and the American Pharmacists Association to promote the PharmGenEd educational campaign to more than 100,000 pharmacists and Healthcare Professionals.
The objective of the proposed PharmGenEd program is to increase awareness about current knowledge of the validity and utility of pharmacogenomic tests and the potential implications of benefits and harms from use of the tests. The program team will work closely with the Centers for Disease Control and Prevention (CDC) and incorporate Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group recommendations. Specifically, proposal aims are to: 1) Develop a two-module educational curriculum focusing on pharmacogenomics primer concepts and clinical applications in concentrated therapeutic areas; 2) Disseminate the educational curriculum to pharmacists, students, and other healthcare professionals using live and online methods, including web-based virtual communities with “pubcasts” (publication and videocast); and 3) Evaluate outcomes and processes of the education program in different audience groups and delivery methods.
This project is funded by the CDC from 2008 to 2011. The program core members are UCSD faculty members: Grace M. Kuo, PharmD, MPH (Principal Investigator/Program Director), Kelly C. Lee, PharmD, Joseph D. Ma, PharmD, James R. Halpert, PhD, Philip E. Bourne, PhD, Palmer W. Taylor, PhD, and Theodore Ganiats, MD. Consultants include Karen S. Hudmon, DrPH, MS, RPh (Purdue University) and Magnus Ingelman-Sundberg, PhD (Karolinska Institute in Sweden). The Program's main speaker is Dr. Howard L. McLeod, Director of the University of North Carolina Institute for Pharmacogenomics and Individualized Therapy.
We welcome healthcare professionals, academicians, and researchers to join this virtual community. We will send updates and news to group members and use this platform for group discussions. Pharmacogenomics educational materials will be posted via the SciVee website and linked to other websites that are currently under development (see web address listed below).
The objective of the proposed PharmGenEd program is to increase awareness about current knowledge of the validity and utility of pharmacogenomic tests and the potential implications of benefits and harms from use of the tests. The program team will work closely with the Centers for Disease Control and Prevention (CDC) and incorporate Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group recommendations. Specifically, proposal aims are to: 1) Develop a two-module educational curriculum focusing on pharmacogenomics primer concepts and clinical applications in concentrated therapeutic areas; 2) Disseminate the educational curriculum to pharmacists, students, and other healthcare professionals using live and online methods, including web-based virtual communities with “pubcasts” (publication and videocast); and 3) Evaluate outcomes and processes of the education program in different audience groups and delivery methods.
This project is funded by the CDC from 2008 to 2011. The program core members are UCSD faculty members: Grace M. Kuo, PharmD, MPH (Principal Investigator/Program Director), Kelly C. Lee, PharmD, Joseph D. Ma, PharmD, James R. Halpert, PhD, Philip E. Bourne, PhD, Palmer W. Taylor, PhD, and Theodore Ganiats, MD. Consultants include Karen S. Hudmon, DrPH, MS, RPh (Purdue University) and Magnus Ingelman-Sundberg, PhD (Karolinska Institute in Sweden). The Program's main speaker is Dr. Howard L. McLeod, Director of the University of North Carolina Institute for Pharmacogenomics and Individualized Therapy.
We welcome healthcare professionals, academicians, and researchers to join this virtual community. We will send updates and news to group members and use this platform for group discussions. Pharmacogenomics educational materials will be posted via the SciVee website and linked to other websites that are currently under development (see web address listed below).
Latest discussionscreate a topic | view all
No discussion topic has been created in this community.
Why don't you start a discussion?
Why don't you start a discussion?
Membersview all
